Page 2 - 90 7 News Today

Its their job to look at the clinical trial, and a, did it work, and b, were there safety concerns. lets take a look at the efficacy data that these advisers are looking at right now. what pfizer found in a large clinical trial with children ages 5 to 11, the vaccine was 90.7 effective at protecting those children against getting sick from covid-19. what they did is they gave more than 1,300 children in the trial the vaccine. they followed them over time, and only three became sick with covid-19...

Available data is a nice summary of what the data show. its important to have this review process, including independent advisory meetings open to the public. i think transparency has been key to public trust. the scientific advisers are debating both the benefits and the risks of vaccination as well as the risks of covid-19 infection in our children. so as a parent, and as pediatrician, the questions that i always ask are, is it safe, is it effective, and will it be impactful in the lives of ch...

Authorization for children age 5s to 11 for pfizer. and then by monday, the fda will have their final decision on emergency use authorization. and then november 2nd and 3rd, next week, cdc advisor, again, external advisers, not a part of the cdc, theyll meet to discuss the specifics of it and whether theyll green light it. after november 3rd, and we think it will be quite soon after 3rd, dr. rochelle walensky, the director of the cdc, would give her thoughts on whether this should be approved th...

Age 5 through 11. in just a few hours the advisory committee will vote on the data specifically whether the benefits of vaccinating children outweigh the potential risk. this is the first key meeting in a regulatory process that could finish up as soon as the end of next week and means 28 million children may be able to roll up their sleeves within days. pfizers involves two shots three weeks apart and each contains one-third of the dose used on adult. a clinical trial of more than 2,000 childre...

An advisory committee is set to meet tomorrow about the pfizer shot for children. pfizers was 90.7% at preventing covid one week after children got their second shot. an fda analysis found the benefits of vaccinating children clearly outweighed the risks in the majority of scenarios. joining me to talk about this is dr. vin gupta. covid vaccine for kids appear like theyre on the horizon. we have an fda vote tomorrow on whether the benefits of the pfizer vaccine outweigh the risk for children. an...

♪ oh what a wonderful world ♪ pfizers released new data showing its covid vaccine is 90.7% effective against symptomatic covid in children

The Pfizer/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of five to 11-year-olds, the U.S. drugmaker said on Friday.Sixteen children in the trial who had received a placebo got COVID-19, compared with 3 who were vaccinated, Pfizer said in briefing documents submitted to the U.S. Food and Drug...

How did panera come up with the idea to combine their famous mac and cheese with their iconic grilled cheese? by saying yes. yes to new inventions! yes to clean and fresh ingredients! and yes to living life to the flavor-fullest. panera. live your yes. now $1 delivery. we may be one step closer to getting younger children vaccinated against covid. the fda is meeting next week to consider vaccines for kids ages 5 to 11 years old. this morning they just posted the data from pfizer that they will...

Against symptomatic covid infection for kids in that age group. it comes as the cdc expands its booster program for adults to include now all three vaccines in the u.s. joining me now is cnn medical analyst dr. leana wen, the former health commissioner for the city of baltimore. 90.7% effective against symptomatic covid, dr. wen. what do you think of this data, and how does it compare to the vaccines effectiveness in other age groups? >> this is good, kate. so i am reassured that there will at l...

Booster. if you had the johnson & johnson product, you should get a booster. there are other segments of folks that as we learn more that will benefit from boosting. but we have to actually vaccinate the unvaccinated. >> in terms of getting some unvaccinated vaccinated, part of that could change, right, when we hopefully approve or see authorization, i should say, for the vaccine for 5- to 11-year-olds. new data from pfizer, theyre saying the vaccine is 90.7% effective against symptomatic covid ...